TG and neoplasm: Recent animal studies have found that the use of tetraiodothyroacetic acid (tetrac), which is a thyroid hormone analogue that inhibits the activation of the membrane receptor integrin αvβ3 on human cancer xenografts lead to tumor regression and decreased tumor growth [70–73].